Adamis Pharmaceuticals CEO Dennis Carlo's 2019 pay rises 18% to $1.8M

Adamis Pharmaceuticals reports 2019 executive compensation

By ExecPay News

Published: July 10, 2020

Adamis Pharmaceuticals reported fiscal year 2019 executive compensation information on July 10, 2020.
In 2019, three executives at Adamis Pharmaceuticals received on average a compensation package of $1.5M, a 38% increase compared to previous year.
Average pay of disclosed executives at Adamis Pharmaceuticals
Dennis J. Carlo, Chief Executive Officer, received $1.8M in total, which increased by 18% compared to 2018. 60.60% of Carlo's compensation, or $1.1M, was in stock awards. Carlo also received $667K in salary and $30.6K in other compensation.
Ronald B. Moss, Chief Medical Officer, received a compensation package of $1.3M, which increased by 61% compared to previous year. 64.07% of the compensation package, or $858.2K, was in stock awards.
Robert O. Hopkins, Chief Financial Officer, earned $1.3M in 2019, a 36% increase compared to previous year.

Related executives

Dennis Carlo

Adamis Pharmaceuticals

Chief Executive Officer

Robert Hopkins

Adamis Pharmaceuticals

Chief Financial Officer

Ronald Moss

Adamis Pharmaceuticals

Chief Medical Officer

You may also like

Source: SEC filing on July 10, 2020.